brexit
EMA relocation will cause drug approval delays even in best case scenario, agency says
September 27, 2017Research and Development EMA, brexit, pharma, pharmaceuticals
As a direct result of the UK’s referendum vote to leave the EU last year, the headquarters of the EMA, …
UK’s post-Brexit strategy looks to life sciences industry
August 30, 2017Medical Communications, Research and Development UK, biotech, brexit, drugs, life sciences, pharma, pharmaceutical
The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …
EMA reveals ‘business continuity plan’ for Brexit, cuts resources from non-essential areas
August 2, 2017Medical Communications, Research and Development EMA, brexit, drugs, life sciences, medicines, pharma, pharmaceutical
The uncertainty caused by Brexit has been and continues to be far-reaching, and perhaps most impactful for business, organisations and …
Brexit Health Alliance warns that UK/EU negotiations put patients at risk
August 1, 2017Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BioIndustry Association, Brexit Health Alliance, NHS, brexit, drugs, healthcare, life sciences, pharma, pharmaceuticals
Last month saw the formation of the Brexit Health Alliance, a partnering of key pharma and life sciences organisations including …
Top Ten most popular articles on Pharmafile.com this week
July 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Teva, biotech, brexit, drugs, healthcare, pharma, pharmaceutical, psoriasis, top ten
The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …
What pharma should know about the European Unitary Patent in light of Brexit
July 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, biotech, brexit, drugs, healthcare, pharma, pharmaceutical
The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty. Two Brexit-related …
What Brexit means for drug regulation
July 14, 2017Medical Communications, Sales and Marketing biotech, brexit, drugs, healthcare, pharma, pharmaceuticals, regulation
The pharmaceutical sector is one of the most tightly regulated industries, and most of the rules that govern the daily …
UK and EU life sciences demand closer collaboration in joint letter to Brexit negotiators
July 13, 2017Sales and Marketing EU, UK, biotech, brexit, drugs, life sciences, pharma, pharmacuetical
The pharmaceutical and life sciences industries have stressed the importance of cooperation between the EU and the UK in order …
PrimeVigilance is committed to minimising the impact of UK’s Withdrawal from the EU
June 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, primevigilance
Guildford, UK 14th June, 2017
European Medicines Agency: Staying consistent in a turbulent time
June 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, European Medicines Agency, brexit
With Brexit looming, the future of the EMA headquarters in London has been cast in doubt. Pharmafocus spoke to Marie-Agnes …
New game, new rules: Pathways for better and affordable medicines in Europe
June 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, market access
Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), discusses the latest …
Could robots solve the pharma talent crisis?
May 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, UK, brexit, pharma, talent crisis
Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …
The June 2017 issue of Pharmafocus is now live!
May 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders
The latest edition of Pharmafocus is available to read online now!
Brain drain: The experts the UK may lose due to Brexit
May 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit
The regulatory and drug approval process is destined to change once the UK leaves the EU. The problem is, nobody …
European Commission warns UK over drug authorisation validity due to Brexit
May 4, 2017Medical Communications, Sales and Marketing EMA, European Commission, brexit
The European Commission has issued a warning to pharmaceutical firms in the UK over the validity of current and future …
